NASDAQ:TTOO T2 Biosystems (TTOO) Stock Price, News & Analysis $0.0005 0.00 (-37.50%) As of 11/4/2026 01:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsInsider TradesSEC Filings About T2 Biosystems Stock (NASDAQ:TTOO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get T2 Biosystems alerts:Sign Up Key Stats Today's Range$0.0005▼$0.000550-Day Range N/A52-Week Range$0.00▼$0.05Volume1,178 shsAverage Volume9,128 shsMarket Capitalization$10.52 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview T2 Biosystems, Inc. is a medical diagnostics company focused on developing and commercializing technologies for the rapid detection of sepsis-causing pathogens and antimicrobial resistance. Its products are designed to identify infections directly from whole-blood samples, potentially helping healthcare providers begin targeted treatment sooner than with conventional culture-based testing. The company’s principal platform is the T2Dx Instrument, an automated diagnostic system that uses proprietary T2 Magnetic Resonance technology. Tests available for the platform have included T2Bacteria, which detects several common bacterial pathogens associated with bloodstream infections, and T2Candida, which detects Candida species linked to candidemia. T2 Biosystems has also developed tests intended to identify antimicrobial-resistance markers and pathogens associated with other serious infections. Founded in 2006 and headquartered in Lexington, Massachusetts, T2 Biosystems markets its diagnostic products to hospitals, laboratories and other healthcare providers. The company serves customers in the United States and international markets through direct sales and distribution relationships. John Sperzel has served as the company’s president and chief executive officer.AI Generated. May Contain Errors. Read More Receive TTOO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for T2 Biosystems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TTOO Stock News HeadlinesT2 Biosystems Inc.May 19, 2026 | marketwatch.comT2 Biosystems, Inc. Announces Intent to Complete Winding Down of OperationsFebruary 3, 2026 | finance.yahoo.comThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. | Porter & Company (Ad)T2 Biosystems Inc. (TTOO): 2025 Product Pipeline and Strategy Analysis ReportOctober 21, 2025 | finance.yahoo.comTTOO T2 Biosystems, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comT2 Biosystems Inc. (TTOO) After Hours QuoteJune 10, 2025 | nasdaq.comT2 Biosystems initiates major layoffs, seeks asset saleFebruary 22, 2025 | uk.investing.comMedical diagnostics firm T2 Biosystems cuts ‘substantially all’ workersFebruary 18, 2025 | bizjournals.comSee More Headlines TTOO Stock Analysis - Frequently Asked Questions How have TTOO shares performed this year? T2 Biosystems' stock was trading at $0.0050 on January 1st, 2026. Since then, TTOO stock has decreased by 90.0% and is now trading at $0.0005. How were T2 Biosystems' earnings last quarter? T2 Biosystems, Inc. (NASDAQ:TTOO) announced its earnings results on Monday, July, 29th. The medical equipment provider reported ($0.66) EPS for the quarter, topping the consensus estimate of ($0.97) by $0.31. The medical equipment provider earned $1.95 million during the quarter. Read the conference call transcript. When did T2 Biosystems' stock split? T2 Biosystems shares reverse split on Friday, October 13th 2023.The 1-100 reverse split was announced on Friday, October 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. When did T2 Biosystems IPO? T2 Biosystems (TTOO) raised $83 million in an initial public offering (IPO) on Wednesday, August 6th 2014. The company issued 5,200,000 shares at a price of $15.00-$17.00 per share. How do I buy shares of T2 Biosystems? Shares of TTOO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of T2 Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that T2 Biosystems investors own include Bionano Genomics (BNGO), Tesla (TSLA), NIO (NIO), Sorrento Therapeutics (SRNE), NVIDIA (NVDA), SNDL (SNDL) and Canopy Growth (CGC). Company Calendar Last Earnings7/29/2024Today11/04/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TTOO CIK1492674 Webwww.t2biosystems.com Phone(781) 761-4646Fax781-357-3080Employees113Year Founded2006Profitability EPS (Trailing Twelve Months)($3.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$50.08 million Net Margins-563.16% Pretax Margin-559.52% Return on EquityN/A Return on Assets-174.06% Debt Debt-to-Equity RatioN/A Current Ratio0.40 Quick Ratio0.24 Sales & Book Value Annual Sales$7.68 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($6.91) per share Price / Book0.00Miscellaneous Outstanding Shares21,043,000Free Float21,037,000Market Cap$10.52 thousand OptionableNo Data Beta8.41 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:TTOO) was last updated on 11/4/2026 by MarketBeat.com Staff. From Our Partners$250,000/Month- How You Can Learn from President TrumpPresident Trump has reportedly collected up to $250,000 a month from a single fund. Now investors can get a...The Oxford Club | SponsoredThe 401k Email 70 Million Investors Might DeleteAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis little-known fund tracks gold and pays out weeklyA little-known $15 fund tied to gold could pay you cash every Friday, no mining stock required. In one rece...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
